Compare ASTE & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASTE | ABSI |
|---|---|---|
| Founded | 1972 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 997.8M |
| IPO Year | 2003 | 2021 |
| Metric | ASTE | ABSI |
|---|---|---|
| Price | $53.03 | $7.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $66.00 | $6.96 |
| AVG Volume (30 Days) | 163.9K | ★ 4.6M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.85% | N/A |
| EPS Growth | ★ 784.21 | 10.64 |
| EPS | ★ 0.06 | N/A |
| Revenue | N/A | ★ $4,534,000.00 |
| Revenue This Year | $14.72 | $215.96 |
| Revenue Next Year | $5.44 | $319.10 |
| P/E Ratio | $876.17 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $37.83 | $2.24 |
| 52 Week High | $65.69 | $8.17 |
| Indicator | ASTE | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 53.33 | 61.78 |
| Support Level | $50.25 | $2.76 |
| Resistance Level | $54.17 | N/A |
| Average True Range (ATR) | 2.04 | 0.79 |
| MACD | 0.50 | 0.02 |
| Stochastic Oscillator | 76.31 | 60.73 |
Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. The company has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.